Vahlquist A, Fischer J, Törmä H. Inherited Nonsyndromic Ichthyoses: An Update on Pathophysiology, Diagnosis and Treatment. Am J Clin Dermatol. 2018 Feb;19(1):51-66.
Oji V, Tadini G, Akiyama M, et al. : Revised nomenclature and classification of inherited ichthyoses: results of the First Ichthyosis Consensus Conference in Sorèze 2009. J Am Acad Dermatol.2010;63(4):607 41.
Kirchmeier P, Zimmer A, Bouadjar B, Rosler B, Fischer J. Whole-exome-sequencing reveals small deletions in CASP14 in patients with autosomal recessive inherited ichthyosis. Acta Derm Venereol. 2017;97(1):102 104.
Sato J, Denda M, Nakanishi J, Nomura J, Koyama J. Cholesterol sulfate inhibits proteases that are involved in desquamation of stratum corneum. J Invest Dermatol. 1998;111(2):189 193..
Ohno Y, Nakamichi S, Ohkuni A, et al. : Essential role of the cytochrome P450 CYP4F22 in the production of acylceramide, the key lipid for skin permeability barrier formation. Proc Natl Acad Sci U S A. 2015;112(25):7707 12.
Radner FP, Marrakchi S, Kirchmeier P, et al. : Mutations in CERS3 cause autosomal recessive congenital ichthyosis in humans. PLoS Genet. 2013;9(6):e1003536.
Eckl KM, Tidhar R, Thiele H, et al. : Impaired epidermal ceramide synthesis causes autosomal recessive congenital ichthyosis and reveals the importance of ceramide acyl chain length. J Invest Dermatol.2013;133(9):2202 11.
Hotz A, Oji V, Bourrat E, Jonca N, Mazereeuw-Hautier J, Betz RC, et al. Expanding the clinical and genetic spectrum of KRT1, KRT2 and KRT10 mutations in keratinopathic ichthyosis. Acta Derm Venereol. 2016;96:473 478.
Zaki Т., Choate K. Recent advances in understanding inherited disorders of keratinization. Version 1. F1000Res. 2018; 7: F1000 Faculty Rev-919.
Brown SJ, Relton CL, Liao H, Zhao Y, Sandilands A, McLean WH, et al. Filaggrin haploinsufficiency is highly penetrant and is associated with increased severity of eczema: further delineation of the skin phenotype in a prospective epidemiological study of 792 school children. Br J Dermatol. 2009;161(4):884 889.
Yoneda K. Inherited ichthyosis: syndromic forms. J Dermatol. 2016;43(3):252 263.
Cavenagh A, Chatterjee S, Davies W. Behavioural and psychiatric phenotypes in female carriers of genetic mutations associated with X-linked ichthyosis. PLoS One. 2019 Feb 15;14(2):e0212330.
Мордовцев В.Н. Наследственные болезни и пороки развития кожи: Атлас. М.: Наука, 2004. 174 с.
Rout D.P., Nair A., Gupta A. Kumar P. Epidermolytic hyperkeratosis: clinical update. Clin Cosmet Investig Dermatol. 2019; 12: 333 344.
Vahlquist A, Bygum A, Ganemo A, Virtanen M, Hellstrom-Pigg M, Strauss G, et al. Genotypic and clinical spectrum of self-improving collodion ichthyosis: ALOX12B, ALOXE3, and TGM1 mutations in Scandinavian patients. J Invest Dermatol 2010;130:438-43..
Беликов А.Н., Альбанова В.И., Комлева Л.Ф., Гольченко В.А. Ихтиоз Арлекина (плод Арлекина): описание случая. // Вестник дерматологии и венерологии, 2012. - №3. с.80-85.
McLean WH. Filaggrin failure—from ichthyosis vulgaris to atopic eczema and beyond. Br J Dermatol. 2016;175(Suppl 2):4 7
Frascari F, Dreyfus I, Rodriguez L et al. Prevalence and risk factors of vitamin D deficiency in inherited ichthyosis: a French prospective observational study performed in a reference center. Orphanet J Rare Dis 2014;9:127.
Neema S, Mukherjee S, Vasudevan B et al. Vitamin D Deficiency After Oral Retinoid Therapy for Ichthyosis. Pediatr Dermatol 2015;32:e151-5.
Perry TB, Holbrook KA, Hoff MS, Hamilton EF, Senikas V, Fisher C. Prenatal diagnosis of congenital non‐bullous ichthyosiform erythroderma (lamellar ichthyosis). Prenat Diagn. 1987;7(3):145 155.
Vahlquist A, Ganemo A, Virtanen M. Congenital ichthyosis: an overview of current and emerging therapies. Acta Derm Venereol. 2008;88(1):4 14.
Hernandez-Martin A, Aranegui B, Martin-Santiago A, Garcia-Doval I. A systematic review of clinical trials of treatments for the congenital ichthyoses, excluding ichthyosis vulgaris. J Am Acad Dermatol. 2013;69(4):544 9.
Vahlquist A. Treatment of rare keratinization disorders: what’s new? Expert Rev Dermatol. 2011;6:211 216.].
Traupe H, Fischer J, Oji V. Nonsyndromic types of ichthyoses an update. JDDG J Dtsch Dermatol Ges 2014;12:109 ‑21.
Ramirez ME, Youseef WF, Romero RG, Martinez JM, Gonzalez-Ensenat MA, Vilaplana XS, et al. Acute percutaneous lactic acid poisoning in a child. Pediatr Dermatol. 2006;23(3):282 285..
Альбанова В.И., Иванов О.Л., Кубанова А.А., Никулин Н.К., Перламутров Ю.Н., Рассказов Н.И. Результаты применения нового отечественного препарата мази 0,5% ретинола пальмитата (Видестим) в дерматологической практике. Вестн. дерматол. 2001, № 3, с. 62-65.
Альбанова В.И. Ретинол и ретиноиды в дерматологии. Российский журнал кожных и венерических болезней. 2000, 3, 72.
Lucker GP, van de Kerkhof PC, van Dijk MR, Steijlen PM. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol. 1994;131(4):546 550.
Kragballe K, Steijlen PM, Ibsen HH et al. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double -blind, vehicle - controlled, right/left comparative study. Arch Dermatol 1995;131:556 ‑60.
Fleckman P, Newell BD, van Steensel MA et al. Topical treatment of ichthyoses. Dermatol Ther 2013;26:16 ‑25.
Коколина В.Ф., Картелищев А.В., Альбанова В.И., Родионова Г.М., Ноздрин К.В. Технология системной ретинолотерапии в педиатрической практике. (Метод. рек. №10). М.: изд. ЗАО «Ретиноиды». 2007. 44 с.
Digiovanna JJ, Mauro T, Milstone LM, Schmuth M, Toro JR. Systemic retinoids in the management of ichthyoses and related skin types. Dermatol Ther. 2013;26(1):26 38.
Katugampola RP, Finlay AY. Oral retinoid therapy for disorders of keratinization: single-centre retrospective 25 years’ experience on 23 patients. Br J Dermatol 2006;154:267‑76.].